The central question in pituitary apoplexy — whether to operate — has been substantially clarified by recent evidence. A prospective multicenter observational study found that surgical and non-surgical management yielded similar hormonal, visual, and oculomotor recovery at three and six months, and that the timing of surgery did not significantly affect outcomes; a meta-analysis of over 900 patients similarly found no significant differences between conservative and surgical management across the key recovery endpoints. Together these support individualized management: initial hemodynamic stabilization, correction of electrolytes, and stress-dose glucocorticoids for all, with surgery (via the endoscopic endonasal transsphenoidal route) reserved for severe or progressive visual deficits or neurological deterioration rather than applied routinely.
Further reading: surgical vs nonsurgical management of pituitary apoplexy (Mamelak et al., JCEM 2024); meta-analysis of 908 patients (Marin-Castañeda et al., 2024).